Difference between revisions of "Team:Paris Saclay/Engagement"
Naianerios (Talk | contribs) (→Engagement) |
Naianerios (Talk | contribs) (→Engagement) |
||
| Line 5: | Line 5: | ||
Guided by curiosity we tried to establish a public dialogue beyond the lab on the societal issues on the CRISPR/Cas9 technology. We met public and stakeholders and tried to combine their contributions. | Guided by curiosity we tried to establish a public dialogue beyond the lab on the societal issues on the CRISPR/Cas9 technology. We met public and stakeholders and tried to combine their contributions. | ||
We wanted for everyone the possibility to express an opinion over science. Everyone should be able to question Synthetic Biology, either if you're a professional or a citizen. This is even more true with the CRISPR/Cas9 technology. The ethical question behind is so big that every citizen should be involved. | We wanted for everyone the possibility to express an opinion over science. Everyone should be able to question Synthetic Biology, either if you're a professional or a citizen. This is even more true with the CRISPR/Cas9 technology. The ethical question behind is so big that every citizen should be involved. | ||
| − | We tried to gather all | + | We tried to gather all opinions on [[Team:Paris_Saclay/HP/Silver|the societal issues of CRISPR/Cas9]] from different fields, but also from public and professionals. We then tried to spread these informations amongst general audiences. |
Our concern about Public Engagement was so strong we made "[[Team:Paris_Saclay/HP/Gold#Inclusiveness_and_Deliberation|Inclusiveness]]" one of the principles of our Responsible Research and Innovation Test. To learn more about it, see our researches on [[Team:Paris_Saclay/HP/Gold|Responsible Research and Innovation]]. When we asked to 18 teams to fill this test we saw how much inclusiveness is important among iGEM teams. | Our concern about Public Engagement was so strong we made "[[Team:Paris_Saclay/HP/Gold#Inclusiveness_and_Deliberation|Inclusiveness]]" one of the principles of our Responsible Research and Innovation Test. To learn more about it, see our researches on [[Team:Paris_Saclay/HP/Gold|Responsible Research and Innovation]]. When we asked to 18 teams to fill this test we saw how much inclusiveness is important among iGEM teams. | ||
| Line 11: | Line 11: | ||
First, we tried to build a strong outreach. In order to do so, we did a [[Team:Paris_Saclay/HP/Silver#Synthetic_Biology_Survey|survey]] to know how much people knew about synthetic biology and CRISPR/Cas9 and what were their feelings about it. We also made a vox pop [[Team:Paris_Saclay/HP/Silver#Vox_Pop|vox pop]] for the same reasons. Thus we explained more what these techniques represent through many exhibitions like the one at the Festival Vivant and the Nanterre University. | First, we tried to build a strong outreach. In order to do so, we did a [[Team:Paris_Saclay/HP/Silver#Synthetic_Biology_Survey|survey]] to know how much people knew about synthetic biology and CRISPR/Cas9 and what were their feelings about it. We also made a vox pop [[Team:Paris_Saclay/HP/Silver#Vox_Pop|vox pop]] for the same reasons. Thus we explained more what these techniques represent through many exhibitions like the one at the Festival Vivant and the Nanterre University. | ||
We learned a lot on CRISPR/Cas9 by [[Team:Paris_Saclay/HP/Silver#Meeting_Stakeholders|meeting politics, scientists and patent Attorneys]]. We conducted many interviews with people working with the CRISPR/Cas9 technology and we saw a lot of variation between the opinion of scientists in general and scientists working specifically with the CRISPR/Cas9 technology. | We learned a lot on CRISPR/Cas9 by [[Team:Paris_Saclay/HP/Silver#Meeting_Stakeholders|meeting politics, scientists and patent Attorneys]]. We conducted many interviews with people working with the CRISPR/Cas9 technology and we saw a lot of variation between the opinion of scientists in general and scientists working specifically with the CRISPR/Cas9 technology. | ||
| − | At last, we connected public and stakeholders during a conference on the societal issues of the CRISPR/Cas9 technology.[[Team:Paris_Saclay/HP/Silver#Conference_about_The_Societal_Issues_of_CRISPR_Cas9|conference on the societal issues of CRISPR/Cas9]]. Our | + | At last, we connected public and stakeholders during a conference on the societal issues of the CRISPR/Cas9 technology.[[Team:Paris_Saclay/HP/Silver#Conference_about_The_Societal_Issues_of_CRISPR_Cas9|conference on the societal issues of CRISPR/Cas9]]. Our lecturers were Jean-Denis Faure, professor at AgroParisTech and Pierre Walrafen, patent Attorney. |
{{Team:Paris_Saclay/project_footer}} | {{Team:Paris_Saclay/project_footer}} | ||
Latest revision as of 15:58, 19 October 2016
